Colgate-Palmolive

CL

Market cap $66.5B

This business is already outperforming so far in 2026.

CL braces for tariff volatility into 2026, leaning on supply-chain shifts, pricing discipline and productivity gains to defend margins.

For the second-straight year and third time in five years, the Dow, S&P 500, and Nasdaq started off the calendar with quarterly losses. ‘Didn't get off the bus,' is the apt sports colloquial that comes to mind.

Investors looking for stocks in the Consumer Products - Staples sector might want to consider either Ahold NV (ADRNY) or Colgate-Palmolive (CL). But which of these two stocks is more attractive to value investors?

CL's Hill's Pet Nutrition outperforms a soft market as prescription diets, cat growth and science-led innovation drove share gains and sustained momentum.

Colgate-Palmolive expects to drive growth in North America this year, in part with new versions of products in oral and skin care.

Colgate-Palmolive (NYSE:CL) lost a key Wall Street backer on Tuesday as TD Cowen analyst Robert Moskow downgraded the stock from Buy to Hold and cut his price target to $85 from $96, citing surging oil-based input costs tied to the Iran War.

Colgate-Palmolive's recent decline has the stock squarely in correction territory. The recent 13.6% drop in just a month may be a case of too much too fast.

The ongoing Iran-Israel-US war, Strait of Hormuz closure, and global economic risks. James Kostohryz explains why disruptions could persist for months.

A federal judge on ​Friday said Colgate-Palmolive must face two lawsuits claiming its packaging for mouth ‌rinse misleads parents into believing children under 6 can use the products safely. The judge dismissed a similar lawsuit concerning Colgate toothpaste.